You are writing regarding

H.R.3497 MODDERN Cures Act of 2011, 112th Congress

Contact Congress

1. Choose Your Position
2. Write Your Letter
3. Share Your Communication

OpenCongress Message Builder

OpenCongress Message Builder

Use the tools in this column to help craft your letter. Anytime your mouse highlights a section, click on it to add prepared text. You can edit any part of the message at left, and if you like, add your own stories and text to personalize your letter.

Official Bill Info

  • Latest Action: Dec 02, 2011 Referred to the Subcommittee on Intellectual Property, Competition and the Internet.

    Clicking this will add the following text:

    I know the most recent action for this bill is as follows: "Referred to the Subcommittee on Intellectual Property, Competition and the Internet." on Dec 02, 2011
  • Committee Assignment: House Committee on Energy and Commerce

    Clicking this will add the following text:

    This bill has been assigned to the House Committee on Energy and Commerce committee.
  • Committee Assignment: House Committee on Ways and Means

    Clicking this will add the following text:

    This bill has been assigned to the House Committee on Ways and Means committee.
  • Committee Assignment: House Committee on the Judiciary

    Clicking this will add the following text:

    This bill has been assigned to the House Committee on the Judiciary committee.
  • Committee Assignment: House Committee on Judiciary - Intellectual Property, Competition and the Internet

    Clicking this will add the following text:

    This bill has been assigned to the House Committee on Judiciary - Intellectual Property, Competition and the Internet committee.
  • Committee Assignment: House Committee on Energy and Commerce - Health

    Clicking this will add the following text:

    This bill has been assigned to the House Committee on Energy and Commerce - Health committee.

Bill Statistics on OpenCongress

  • 100% of users support H.R.3497

    Clicking this will add the following text:

    100% of users on OpenCongress.org, a free, non-partisan resource, support H.R.3497.
  • H.R.3497 has been viewed 2,309 times

    Clicking this will add the following text:

    H.R.3497 has been viewed 2,309 times on OpenCongress.org, a free, non-partisan resource.
  • Contribution Data

    Enter your street address above, and relevant campaign contribution data for your elected officials will appear here in seconds for you to use in your letter.

    Most-commented sections of the bill text

    Highest Rated User Comments

    Highly Rated Blog Articles

    • Faculty Bulletin Board / UCLA Today - March 26, 2012 by http://www.today.ucla.edu/news/ - Rhonda Voskuhl. Dr. Rhonda Voskuhl, professor of neurology and director of the UCLA Multiple Sclerosis Program, testified before Congress on Feb. 28 in support of H.R. 3497, a bill that would develop a new framework for drug approval that ...

      Clicking this will add the following text:

      As noted by http://www.today.ucla.edu/news/ on March 26, 2012, "Rhonda Voskuhl. Dr. Rhonda Voskuhl, professor of neurology and director of the UCLA Multiple Sclerosis Program, testified before Congress on Feb. 28 in support of H.R. 3497, a bill that would develop a new framework for drug approval that ..." (/url?q=http://today.ucla.edu/portal/ut/faculty-news.aspx&sa=U&ei=4bhxT7P6CuOU2wXGxNDmDg&ved=0CEIQmAEwBw&usg=AFQjCNEW3islpsKScSqr3DUE1t6B_-grIw)
    • Faculty Bulletin Board / UCLA Today - March 24, 2012 by http://www.today.ucla.edu/news/ - Rhonda Voskuhl. Dr. Rhonda Voskuhl, professor of neurology and director of the UCLA Multiple Sclerosis Program, testified before Congress on Feb. 28 in support of H.R. 3497, a bill that would develop a new framework for drug approval that ...

      Clicking this will add the following text:

      As noted by http://www.today.ucla.edu/news/ on March 24, 2012, "Rhonda Voskuhl. Dr. Rhonda Voskuhl, professor of neurology and director of the UCLA Multiple Sclerosis Program, testified before Congress on Feb. 28 in support of H.R. 3497, a bill that would develop a new framework for drug approval that ..." (/url?q=http://today.ucla.edu/portal/ut/faculty-news.aspx&sa=U&ei=mxhvT9zYMKHKsQK2u4HuBQ&ved=0CEIQmAEwBw&usg=AFQjCNFmP3-1cvAcMrAFhJYECq39x9zRsg)
    • Faculty Bulletin Board / UCLA Today - March 23, 2012 by http://www.today.ucla.edu/news/ - Rhonda Voskuhl. Dr. Rhonda Voskuhl, professor of neurology and director of the UCLA Multiple Sclerosis Program, testified before Congress on Feb. 28 in support of H.R. 3497, a bill that would develop a new framework for drug approval that ...

      Clicking this will add the following text:

      As noted by http://www.today.ucla.edu/news/ on March 23, 2012, "Rhonda Voskuhl. Dr. Rhonda Voskuhl, professor of neurology and director of the UCLA Multiple Sclerosis Program, testified before Congress on Feb. 28 in support of H.R. 3497, a bill that would develop a new framework for drug approval that ..." (/url?q=http://today.ucla.edu/portal/ut/faculty-news.aspx&sa=U&ei=A7t1T8XSIoae8gSJ4p2BBA&ved=0CEIQmAEwBw&usg=AFQjCNGwaSwgAPhSTKKI98L-wvho3dMQ3A)

    Highly Rated News Articles

    Enter your street address at right to find your members of Congress. You must have JavaScript enabled.
    A Letter to Congress from a constituent via OpenCongress.org

    After sending, this letter will be viewable to:

    Characters Remaining:  
    • Click "Send Message" above to complete delivery of this email. (If you don't already have a free "My OpenCongress" account, we'll make one for you now.)
    • Congressional offices require all address information in the form above be completed in order to deliver your email.
    • OpenCongress does not share your address information with any outside parties for any reason.

    OpenCongress is the only not-for-profit website that enables you to write all three of your members of Congress at once.

    OpenCongress is the only website that gives this information back to the public commons, enabling you to find other constituents near you who are tracking the same bills and issues.